Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spre...
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node disse...
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
The purpose of this study is to the 6-month Venous Thromboembolism (VTE)-free rate in participants with advanced germ cell cancer at high risk of VTE who are receiving standard of care cisplatin-based...
Top Cities for Testicular Cancer Clinical Trials
Testicular Cancer clinical trials are recruiting across 6 cities. Here are the cities with the most active studies:
About Testicular Cancer
Testicular cancer develops in the testicles and is the most common cancer in young men ages 15-35. It has a very high cure rate, even when diagnosed at advanced stages. Treatment includes surgery, chemotherapy, and radiation therapy.
Clinical trials are advancing new treatments for testicular cancer. Currently, 3 studies are recruiting a combined 1,957 participants across the United States. Research is being conducted by 3 organizations including Children's Oncology Group, Indiana University, Wake Forest University Health Sciences.
2026 Testicular Cancer Research Landscape
As of March 2026, the testicular cancer clinical trial landscape includes 3 actively recruiting studies across 6 cities in the United States. These studies are collectively seeking 1,957 participants, with an average enrollment target of 652 per study.
Research is being led by 3 different organizations, including Children's Oncology Group, Indiana University, Wake Forest University Health Sciences.
Geographically, testicular cancer trials are most concentrated in Anchorage, Alaska (8 trials); Indianapolis, Indiana (2 trials); Birmingham, Alabama (1 trial); Mobile, Alabama (1 trial); Charlotte, North Carolina (1 trial) and 1 other cities.
Featured Testicular Cancer Studies
Highlighted recruiting studies for testicular cancer, selected by enrollment size and research scope.
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of t...
Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.
This randomization study is to compare both intrathecal morphine and intravenous methadone, which are both standard of care, for pain management in patients undergoing retroperitoneal lymph node dissections for primary testicular cancer. Investigators plan to compare their analgesic effectiveness at different postoperative time intervals.
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
The purpose of this study is to the 6-month Venous Thromboembolism (VTE)-free rate in participants with advanced germ cell cancer at high risk of VTE who are receiving standard of care cisplatin-based chemotherapy and low-dose acetylsalicylic acid (ASA) and compare to relevant historical controls
Frequently Asked Questions About Testicular Cancer Clinical Trials
Are there testicular cancer clinical trials near me?
Yes, there are 3 testicular cancer clinical trials currently recruiting across 6+ cities in the United States, including Anchorage, Alaska; Indianapolis, Indiana; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a testicular cancer clinical trial?
To join a testicular cancer clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are testicular cancer clinical trials free?
Yes, participation in testicular cancer clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of testicular cancer treatments are being studied?
Current testicular cancer clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 3 research organizations.
Is it safe to participate in testicular cancer clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov